Stay updated on Pembrolizumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section listing Washington as a study site (Seattle, WA) and removed the prior Washington Locations label and the HHS Vulnerability Disclosure link; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:33:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The header now displays Revision: v3.3.2, replacing Revision: v3.3.1. No substantive study information is changed.
    Difference
    0.0%
    Check dated 2025-12-01T17:59:13.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:55:35.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The funding lapse notice about government funding and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T07:10:50.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Administrative updates are present, including a new last update date and posted results, while the core study design, arms, and eligibility remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:42.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:19:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.